Becton, Dickinson and Company BDX, popularly known as BD, announced that the FDA granted 510(k) clearance for its novel blood collection device, MiniDraw. This revolutionary device is likely to ...
BD MiniDraw™ Capillary Blood Collection System Enables Lab-Quality Blood Testing from Less Invasive Method than Venous Collection in More Convenient Locations FRANKLIN LAKES, N.J., Dec. 7, 2023 ...
Becton Dickinson has received 510(k) clearance for a device that collects blood from a fingerstick instead of from the vein. The MiniDraw Capillary Blood Collection System container is slightly larger ...
Theranos had a lot of bad ideas, but making blood draws smaller and easier wasn’t necessarily one of them. A decade after the now-defunct blood-testing startup emerged from stealth, BD has now claimed ...
Becton, Dickinson (NYSE:BDX) on Thursday announced that its novel blood collection device has received 510(k) clearances from the U.S. Federal Drug Administration. BD MiniDraw Capillary Blood ...
FRANKLIN LAKES, N.J. and AUSTIN, Texas, Dec. 17, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Babson Diagnostics, a ...
(RTTNews) - Medical technology company Becton, Dickinson and Co. or BD (BDX) announced Thursday it has received 510(k) clearances from the U.S. Federal Drug Administration (FDA) for a novel blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results